174 results on '"Kim, Do-Young"'
Search Results
2. Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center
3. Modified Korean MIND Diet: A Nutritional Intervention for Improved Cognitive Function in Elderly Women through Mitochondrial Respiration, Inflammation Suppression, and Amino Acid Metabolism Regulation
4. Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus‐related liver cirrhosis
5. Rapidly progressing generalized bullous fixed drug eruption after the first dose of COVID‐19 messenger RNA vaccination
6. Antiviral therapy does not improve outcomes of patients with HBV‐related decompensated cirrhosis and undetectable DNA
7. Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non‐alcoholic fatty liver disease
8. Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment
9. Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone
10. Long‐term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study
11. Skin manifestation as an explaining factor of heterogeneity in Behçet's disease: A focused analysis in full‐blown conditions
12. Expert consensus on the management of adverse events in patients receiving lenvatinib for hepatocellular carcinoma
13. A New Reporting System for Diagnosis of Hepatocellular Carcinoma in Chronic Hepatitis B With Clinical and Gadoxetic Acid‐Enhanced MRI Features
14. Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects
15. Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B
16. Long‐term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B
17. Risk assessment of hepatocellular carcinoma and liver‐related events using ultrasonography and transient elastography in patients with chronic hepatitis B
18. No influence of hepatic steatosis on the 3‐year outcomes of patients with quiescent chronic hepatitis B
19. Risk stratification using sarcopenia status among subjects with metabolic dysfunction‐associated fatty liver disease
20. Association of atrial fibrillation and various cancer subtypes
21. Substance P ameliorates TNF‐α‐mediated impairment of human aortic vascular cells in vitro
22. Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea
23. External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals
24. Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B
25. Metabolic activity assessment by 18 F‐fluorodeoxyglucose positron emission tomography in patients with hepatocellular carcinoma undergoing Yttrium‐90 transarterial radioembolization
26. Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes
27. Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma
28. Pharmacokinetics and safety of evogliptin in hepatically impaired patients
29. Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir
30. Dexmedetomidine combined with suprascapular nerve block and axillary nerve block has a synergistic effect on relieving postoperative pain after arthroscopic rotator cuff repair
31. A multi‐centre study of trends in hepatitis B virus‐related hepatocellular carcinoma risk over time during long‐term entecavir therapy
32. High body mass index hinders fibrosis improvement in patients receiving long‐term tenofovir therapy in hepatitis B virus‐related cirrhosis
33. Entecavir and tenofovir on renal function in patients with hepatitis B virus‐related hepatocellular carcinoma
34. Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase
35. An observational study on long‐term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate
36. Impact of age on thromboembolic events in patients with non‐valvular atrial fibrillation
37. Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
38. External validation of the modified PAGE‐B score in Asian chronic hepatitis B patients receiving antiviral therapy
39. Real‐world safety evaluation of topical corticosteroid use: A community pharmacy‐based, prospective, observational study
40. Oil resistance and low‐temperature characteristics of plasticized nitrile butadiene rubber compounds
41. LPS‐induced mTORC1 Signaling Activates Lipid Raft‐Actin Cytoskeletal Interactions for Phagocytosis through SREBP‐1a
42. Fibrosis‐matched outcomes between chronic hepatitis B patients with drug‐induced virological response and inactive carriers
43. Impact Print-Type Hot Embossing Process Technology
44. The Ketogenic Diet Attenuates Both Hyperactivity in mTOR pathway and Astrogliosis Through Regulation of AMPK signaling in the Epileptic Brain
45. Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib
46. Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance
47. Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B
48. Gamma‐glutamyl transpeptidase‐to‐platelet ratio is an independent predictor of hepatitis B virus‐related liver cancer
49. Validation of PAGE‐B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir
50. Effects of compatibility on foaming behavior of polypropylene/polyolefin elastomer blends prepared using a chemical blowing agent
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.